Onterris, Inc. (ONT) News
Track canonical SquawkNews coverage tagged to ONT, Onterris, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 16 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ONT - Onterris Builds Momentum in National Brownfields & Community Revitalization Practice
ONT - Onterris Builds Momentum in National Brownfields & Community Revitalization Practice
NEWS | Sep 24, 2026, 01:07 PM UTC
L
Onterris (ONT) Books $14M YTD Brownfields Work; ~$5M Revenue Through July
Onterris reported securing $14M+ in new Brownfields & Community Revitalization work YTD 2026 and generating nearly $5M in revenue through July. The team also supported client wins of $20M+ in FY2026 EPA Brownfield grants
EARNINGS | Sep 24, 2026, 01:02 PM UTC
L
Onterris Builds Momentum in National Brownfields & Community Revitalization Practice
Onterris (NYSE: ONT) a global environmental solutions company solving complex challenges for planet and progress, today announced strong year-to-date 2026 momentum in its Brownfields & Community Revitalization practice,
NEWS | Sep 24, 2026, 01:02 PM UTC
M
Oxford Nanopore wins preliminary injunction in Unified Patent Court
Oxford Nanopore Technologies says the Unified Patent Court granted a preliminary injunction against MGI Tech, per its update.
REGULATION | Sep 16, 2026, 06:31 AM UTC
L
ONT: Clinical and biopharma growth, margin gains, and strategic focus drive positive outlook to 2027
Strong device sales and margin improvements offset regional headwinds, with clinical and biopharma segments driving growth. Strategic focus has shifted to high-value applications, operational discipline, and leveraging A
EARNINGS | Sep 15, 2026, 04:43 PM UTC
L
ONT: Clinical and biopharma growth, margin gains, and AI-driven strategy fuel long-term expansion
Strong device sales and margin improvements offset regional headwinds, with clinical and biopharma segments driving growth and a strategic focus on high-value applications. Margin expansion is expected through recycling
EARNINGS | Sep 15, 2026, 03:58 PM UTC
L
Oxford Nanopore to participate in upcoming investor conferences
Oxford Nanopore Technologies plc (LSE: ONT) said it will participate in upcoming investor conferences.
EQUITY | Sep 09, 2026, 06:01 AM UTC
L
Oxford Nanopore CFO buys shares at 162.26p average
Oxford Nanopore CFO Keher (since January 2024) purchased shares at an average price of 162.26p each for £24,867.08 total. At 1530 BST, ONT shares were down 7.16% at 160.90p.
EQUITY | Sep 04, 2026, 02:36 PM UTC
L
Oxford Nanopore director/PDMR shareholding disclosed in RNS
Oxford Nanopore Technologies plc filed an RNS on Director/PDMR notifications for transactions by persons discharging managerial responsibilities and closely associated persons.
EQUITY | Sep 04, 2026, 11:00 AM UTC
H
London mid-caps face biggest weekly fall in three months
London mid-cap stocks were set for their biggest weekly fall in three months on Friday as concerns over soaring government debt and inflation pressured sentiment. Experian slid after the U.S. housing regulator criticised
MACRO | Sep 04, 2026, 10:42 AM UTC
L
Oxford Nanopore reports major-holding voting-rights breakdown TR-1
Oxford Nanopore Technologies plc filed a TR-1 notification for major holdings, citing an event changing the breakdown of voting rights.
EQUITY | Sep 04, 2026, 09:00 AM UTC
M
Onterris (ONT) announces over $9 million in new project awards
Onterris (ONT) says it has received more than $9 million in new project awards from a long-standing global energy client.
EQUITY | Aug 13, 2026, 01:06 PM UTC
L
ONT - Onterris Reports Second Quarter Results, Updates Full-Year 2026 Guidance, and Announces Board-led Strategic Review Process - Click For
ONT - Onterris Reports Second Quarter Results, Updates Full-Year 2026 Guidance, and Announces Board-led Strategic Review Process
EARNINGS | Aug 05, 2026, 08:21 PM UTC
L
Onterris Lowers FY2026 Sales Guidance from $840.000M-$900.000M to $740.000M-$790.000M vs $858.085M Est
Onterris (NYSE: ONT ) lowers FY2026 sales outlook from $840.000 million-$900.000 million to $740.000 million-$790.000 million vs $858.085 million estimate.
EARNINGS | Aug 05, 2026, 08:16 PM UTC
L
ONT Reports Q2 Net Income $1.4m
ONT posts Q2 net income of $1.4m
EARNINGS | Aug 05, 2026, 08:12 PM UTC
L
Onterris Hires Kurt Beil as Executive VP
Onterris hires new executive vice president
EQUITY | Aug 03, 2026, 07:04 PM UTC